Only MET was capable to detect very early tumor response as early as 24 h after initiation of proteasome inhibitor treatment; neither FDG-uptake nor any other tumor marker (Ki-67/proliferation, CD138, Ig light chains) was affected at that time. Here, MKI67 is linked to neoplasm.